Ralliant (NYSE:RAL) Hits New 1-Year Low – What’s Next?

Ralliant Corporation (NYSE:RAL)’s share price hit a new 52-week low on Thursday . The stock traded as low as $37.27 and last traded at $37.7260, with a volume of 2123396 shares. The stock had previously closed at $56.28.

Trending Headlines about Ralliant

Here are the key news stories impacting Ralliant this week:

• Positive Sentiment: Q4 operational beat — Ralliant reported $0.69 EPS vs. $0.67 consensus and fourth‑quarter revenue of ~$555M (above estimates), with revenue up ~1% year‑over‑year and sequential growth. This shows underlying demand resilience. BusinessWire Q4 Release
• Positive Sentiment: End‑market tailwinds in Test & Measurement — Industry coverage notes surging demand for test equipment, a potential driver of revenue stability/recapture going forward. Investing.com: Test Equipment Demand
• Neutral Sentiment: Analyst commentary and metric review — Coverage (Zacks, Yahoo) highlights the quarter’s beat but urges focus on key ratios and ROE analysis given the one‑time charge and mix of results; useful context for modeling but not an immediate catalyst by itself. Zacks: Q4 Metrics
• Negative Sentiment: Large goodwill impairment and GAAP loss — Ralliant recorded a non‑cash $1.4B goodwill impairment (Test & Measurement), producing a GAAP net loss of ~$1.4B (≈ $(12.10)/share). That sizable charge pressures reported profitability metrics and investor sentiment. BusinessWire: Q4 & Impairment
• Negative Sentiment: EPS guidance misses — Ralliant set FY‑2026 EPS guidance of $2.22–2.42 vs. consensus ~2.71 and Q1 EPS guide $0.46–0.52 vs. ~0.53 est.; the FY EPS shortfall is the clearest near‑term reason for downward pressure despite revenue guidance roughly in line. TipRanks: Q4 Results & 2026 Outlook

Wall Street Analysts Forecast Growth

RAL has been the topic of several research analyst reports. Truist Financial assumed coverage on Ralliant in a research report on Friday, December 12th. They issued a “buy” rating and a $62.00 price objective on the stock. Citigroup raised Ralliant from a “neutral” rating to a “buy” rating and lifted their target price for the company from $53.00 to $61.00 in a research note on Monday, December 8th. Royal Bank Of Canada boosted their price target on Ralliant from $45.00 to $52.00 and gave the stock a “sector perform” rating in a report on Friday, November 7th. Barclays increased their price objective on shares of Ralliant from $59.00 to $60.00 and gave the company an “overweight” rating in a report on Wednesday, January 7th. Finally, Oppenheimer boosted their target price on shares of Ralliant from $55.00 to $60.00 and gave the stock an “outperform” rating in a report on Monday, December 15th. Six analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $58.00.

Ralliant Price Performance

The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.03 and a current ratio of 1.49. The firm has a fifty day simple moving average of $51.92 and a two-hundred day simple moving average of $46.83. The firm has a market cap of $4.33 billion and a PE ratio of 30.17.

Ralliant (NYSE:RAL) last posted its earnings results on Wednesday, February 4th. The company reported $0.69 EPS for the quarter, beating analysts’ consensus estimates of $0.67 by $0.02. The firm had revenue of $554.60 million for the quarter, compared to the consensus estimate of $543.04 million. The company’s quarterly revenue was up 1.2% on a year-over-year basis. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 23rd. Shareholders of record on Monday, March 9th will be paid a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date of this dividend is Monday, March 9th. Ralliant’s dividend payout ratio (DPR) is presently 15.75%.

Institutional Trading of Ralliant

Several hedge funds have recently made changes to their positions in RAL. Thrivent Financial for Lutherans grew its position in Ralliant by 3.9% in the fourth quarter. Thrivent Financial for Lutherans now owns 218,251 shares of the company’s stock worth $11,111,000 after acquiring an additional 8,206 shares in the last quarter. Allworth Financial LP lifted its stake in shares of Ralliant by 134.4% in the 4th quarter. Allworth Financial LP now owns 511 shares of the company’s stock valued at $26,000 after purchasing an additional 293 shares during the last quarter. Oregon Public Employees Retirement Fund boosted its holdings in shares of Ralliant by 1.6% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 25,800 shares of the company’s stock worth $1,313,000 after purchasing an additional 400 shares during the period. Ethic Inc. purchased a new position in shares of Ralliant in the 4th quarter worth approximately $767,000. Finally, Sequoia Financial Advisors LLC bought a new position in shares of Ralliant during the 4th quarter valued at approximately $215,000.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.